Financial Statements · Financial Reporting
Novo Nordisk Estonia OÜ
Official identifier 16722379Record date 31 Dec 2024
EstoniaReport
- Legal formThe legal or organisational form recorded by the Estonian Business Register. Learn more
- OÜ
- Report status
- Registered
Dates
- Reporting year
- 2024
- Period start
- 1 Jan 2024
- Submitted date
- 30 Jun 2025
Report
- Consolidated
- No
- Audited
- Yes
Financial metrics
| Statement | Metric | Value |
|---|---|---|
| Balance sheet | Assets | 7,411,786 |
| Balance sheet | Cash and cash equivalents | 141,825 |
| Balance sheet | Current assets | 7,411,786 |
| Balance sheet | Current liabilities | 5,932,219 |
| Balance sheet | Equity | 1,430,185 |
| Balance sheet | Share capital at nominal value | 200,000 |
| Balance sheet | Non-current liabilities | 49,382 |
| Balance sheet | Retained earnings (loss) from previous periods | 217,418 |
| Income statement scheme 1 | Labour costs | -1,717,842 |
| Income statement scheme 1 | Revenue | 28,225,863 |
| Income statement scheme 1 | Annual period profit / loss | 1,012,767 |
| Income statement scheme 1 | Operating profit (loss) | 985,980 |
| Income statement scheme 1 | Profit (loss) before income tax | 1,012,767 |
| Profit distribution proposal | Retained earnings (loss) from previous periods | 217,418 |
| Note: Labour costs | Employees | 18 |
| Note: Labour costs | Labour costs | 1,717,842 |
Linked company
Company: Novo Nordisk Estonia OÜ